219 related articles for article (PubMed ID: 10411479)
1. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
2. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective synthesis of (+)-cryptophycin 52 (LY355703), a potent antimitotic antitumor agent.
Ghosh AK; Swanson L
J Org Chem; 2003 Dec; 68(25):9823-6. PubMed ID: 14656116
[TBL] [Abstract][Full Text] [Related]
4. Novel synthesis, cytotoxic evaluation, and structure-activity relationship studies of a series of alpha-alkylidene-gamma-lactones and lactams.
Janecki T; Błaszczyk E; Studzian K; Janecka A; Krajewska U; Rózalski M
J Med Chem; 2005 May; 48(10):3516-21. PubMed ID: 15887960
[TBL] [Abstract][Full Text] [Related]
5. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
Eissler S; Bogner T; Nahrwold M; Sewald N
Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
7. Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV; Golakoti T; Patterson GM; Moore RE
J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity of gamma-aryl substituted alpha-alkylidene-gamma-lactones and alpha-alkylidene-gamma-lactams.
Albrecht A; Koszuk JF; Modranka J; Rózalski M; Krajewska U; Janecka A; Studzian K; Janecki T
Bioorg Med Chem; 2008 May; 16(9):4872-82. PubMed ID: 18396404
[TBL] [Abstract][Full Text] [Related]
9. Synthetic analogues of the microtubule-stabilizing agent (+)-discodermolide: preparation and biological activity.
Gunasekera SP; Mickel SJ; Daeffler R; Niederer D; Wright AE; Linley P; Pitts T
J Nat Prod; 2004 May; 67(5):749-56. PubMed ID: 15165132
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of cryptophycin 52 using the sharpless asymmetric dihydroxylation: diol to epoxide transformation optimized for a base-sensitive substrate.
Liang J; Moher ED; Moore RE; Hoard DW
J Org Chem; 2000 May; 65(10):3143-7. PubMed ID: 10814209
[TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
[TBL] [Abstract][Full Text] [Related]
13. "Clicktophycin-52": a bioactive cryptophycin-52 triazole analogue.
Nahrwold M; Bogner T; Eissler S; Verma S; Sewald N
Org Lett; 2010 Mar; 12(5):1064-7. PubMed ID: 20131817
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, conformational analysis, and cytotoxicity of conformationally constrained aplidine and tamandarin A analogues incorporating a spirolactam beta-turn mimetic.
Gutiérrez-Rodríguez M; Martín-Martínez M; García-López MT; Herranz R; Cuevas F; Polanco C; Rodríguez-Campos I; Manzanares I; Cárdenas F; Feliz M; Lloyd-Williams P; Giralt E
J Med Chem; 2004 Nov; 47(23):5700-12. PubMed ID: 15509169
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumour activity of new muricatacin and goniofufurone analogues.
Popsavin V; Srećo B; Krstić I; Popsavin M; Kojić V; Bogdanović G
Eur J Med Chem; 2006 Oct; 41(10):1217-22. PubMed ID: 16891043
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of cryptophycins via an N-acyl-beta-lactam macrolactonization.
Vidya R; Eggen M; Nair SK; Georg GI; Himes RH
J Org Chem; 2003 Dec; 68(25):9687-93. PubMed ID: 14656095
[TBL] [Abstract][Full Text] [Related]
17. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
[TBL] [Abstract][Full Text] [Related]
18. Semisynthetic analogues of the microtubule-stabilizing agent discodermolide: preparation and biological activity.
Gunasekera SP; Longley RE; Isbrucker RA
J Nat Prod; 2002 Dec; 65(12):1830-7. PubMed ID: 12502323
[TBL] [Abstract][Full Text] [Related]
19. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of simplified analogues of (+)-discodermolide. Additional insights on the importance of the diene, the C7 hydroxyl, and the lactone.
Smith AB; Xian M
Org Lett; 2005 Nov; 7(23):5229-32. PubMed ID: 16268545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]